Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04076202

Clinical Evaluation of Vanguard DD RP

This is a single cohort, prospective study of performance and safety of the Vanguard Deep Dish Rotating Platform (DD RP) cementless fixation with the goal to acquire clinical outcomes data and evaluate the performance of the device in an Austrian patient population

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kepler Universitäts Klinikum

Linz, 4021, Austria

About this study

This is a single cohort, prospective study of performance and safety of the Vanguard Deep Dish Rotating Platform (DD RP) - cementless fixation with finned stem. The performance will be assessed by Oxford Knee Score, and evaluation of aseptic loosening after 2 years follow up. Patient benefit will be evaluated by means of Knee injury and Osteoarthritis Outcome Score (KOOS) and EQ-5D patient questionnaire. The target enrollment is 113 patients in 1 clinical site in Linz, Austria.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients scheduled to undergo primary total knee replacement:
  • with painful and disabled knee joint resulting from any of the following diagnoses:
  • Osteoarthritis,
  • Traumatic arthritis,
  • Rheumatoid arthritis with one or more compartments involved.
  • Correction of varus, valgus, or posttraumatic deformity.
  • Correction or revision of unsuccessful osteotomy or arthrodesis.
  • Need to obtain pain relief and improve function.
  • Ability and willingness to follow instructions, including control of weight and activity level, and to return for follow-up evaluations.
  • A good nutritional state of the patient.
  • Full skeletal maturity of the patient, patients who are at least 18 years of age.
  • Patients of either sex.
  • Consent form read, understood, and signed by patient.

Exclusion criteria

  • Absolute contraindications include the following diagnoses:
  • Infection
  • Osteomyelitis
  • Previous partial or total prosthetic knee replacement on the operative side
  • Skeletal immaturity of the patient
  • Sepsis
  • Patients who are less than 18 years of age
  • Relative contraindications include:
  • uncooperative patient or patient with neurologic disorders who are incapable of following directions,
  • osteoporosis,
  • metabolic disorders which may impair bone formation,
  • osteomalacia,
  • distant foci of infections which may spread to the implant site,
  • rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram,
  • vascular insufficiency, muscular atrophy, neuromuscular disease,
  • incomplete or deficient soft tissue surrounding the knee

Treatment and study plan

Cementless Vanguard DD RP

Device

Patients treated with the Cementless Vanguard DD RP knee implant

Primary outcomes

  1. Performance

    Time frame: 2 years

    The performance will be assessed by evaluation of the rate of aseptic loosening of femoral or tibial components within 2 years follow up.

Secondary outcomes

  1. Patient benefits

    Time frame: 10 years

    Patient benefit will be evaluated by means of Knee injury and Osteoarthritis Outcome Score (KOOS). The KOOS evaluates both short-term and long-term consequences of knee injury.The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.

  2. Patient benefits

    Time frame: 10 years

    Patient benefit will be evaluated by means of European Quality of Life (EuroQol) in 5 Dimensions (EQ-5D) patient questionnaire. The questionnaire contains a descriptive system and the EQ Visual Analogue scale (VAS). The descriptive system comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression). The EQ VAS records the respondent's self-rated health on a 20 cm vertical, visual analogue scale with endpoints labelled 'the best health you can imagine' and 'the worst health you can imagine'. Higher EQ-5D score values indicate better outcome.

Sponsors and collaborators

Lead sponsor

Zimmer Biomet

Industry

Registry information

Official study title

Clinical Evaluation of Vanguard Deep Dish Rotating Platform Knee - Cementless Fixation With Finned Stem

Important dates

Study start
2013
Primary completion
2018
Study completion
2026
First posted
Sep 3, 2019
Registry last updated
May 17, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.